Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05726747 · ClinicalTrials.gov registry record
QOL and Sarcopenia in Patients With Ascites
A clinical trial of Ascites Hepatic and Ascites, Malignant, sponsored by Abramson Cancer Center at Penn Medicine.
- Recruiting
- Registry status
- 70
- Enrollment target
- 1
- Study location
NCT05726747 is a study of Ascites Hepatic and Ascites, Malignant that is actively recruiting participants, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 70 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05726747, a study of Ascites Hepatic and Ascites, Malignant, is actively recruiting participants, sponsored by Abramson Cancer Center at Penn Medicine.
- RECRUITING
- Registry status
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
Clinical data regarding quality of life in patients with refractory ascites is limited and preceded the development of newer questionnaires that may be more robust. One primary objective of this study is to study changes in quality in life in a prospective fashion using newer general and ascites-specific quality of life survey instruments specific to benign and malignant etiologies. Sarcopenia is a condition that is prevalent in cancer and cirrhosis. Current data is retrospective and associative, evaluating heterogeneous patient populations at different stages within the timeline of refractory ascites. The other primary objective of this study is to study sarcopenia in a prospective fashion and to understand its kinetics once a patient develops refractory ascites. Prospectively-obtained measures of deterioration in patient-reported outcomes and in muscle mass will form the basis for the next stage of investigation of interventions to mitigate these declines.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Quality of Life surveys
Study Locations (1)
Pennsylvania
- University of Pennsylvania Perelman School of Medicine - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2023-05-23 |
| Est. Completion | 2026-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05726747
The ClinicalTrials.gov registry entry for NCT05726747 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Ascites Hepatic appearing as the primary indexed condition, and to 1 intervention - of which Quality of Life surveys is the first listed.
NCT05726747 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05726747 about?
NCT05726747 is a clinical study titled "QOL and Sarcopenia in Patients With Ascites". Clinical data regarding quality of life in patients with refractory ascites is limited and preceded the development of newer questionnaires that may be more robust. One primary objective of this study is to study changes in quality in life in a prospective fashion using newer general and ascites-spe...
What is the current status of trial NCT05726747?
This trial is currently recruiting. The enrollment target is 70 participants. The study started on 2023-05-23. Estimated completion is 2026-10.
What conditions does trial NCT05726747 study?
This clinical trial studies the following conditions: Ascites Hepatic, Ascites, Malignant.
What interventions are being tested in trial NCT05726747?
The interventions under investigation include: Quality of Life surveys (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05726747?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05726747 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ascites Hepatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.